Views & Analysis How does HTA for orphan drugs differ across Europe? New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe.
News SMC approves medicines for breast cancer, skin cancer, schiz... The Scottish Medicines Consortium (SM
Views & Analysis Keeping up the PACE at the Scottish Medicines Consortium (SM... There are many ways that patient centricity could be delivered when doing a health technology assessment (HTA).
Views & Analysis The shadow of Brexit on speed of access No-one can miss the ongoing saga that is the UK’s exit from the European Union (EU).
News NHS use of digital cardiac rehab tools endorsed Seven digital health technologies used to support people recovering from cardiovascular diseases have been recommended for use by the NHS.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
